Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
Oncotarget ; 7(18): 25930-48, 2016 May 03.
Article in English | MEDLINE | ID: mdl-27036018

ABSTRACT

Ovarian cancer presents as an aggressive, advanced stage cancer with widespread metastases that depend primarily on multicellular spheroids in the peritoneal fluid. To identify new druggable pathways related to metastatic progression and spheroid formation, we integrated microRNA and mRNA sequencing data from 293 tumors from The Cancer Genome Atlas (TCGA) ovarian cancer cohort. We identified miR-509-3p as a clinically significant microRNA that is more abundant in patients with favorable survival in both the TCGA cohort (P = 2.3E-3), and, by in situ hybridization (ISH), in an independent cohort of 157 tumors (P < 1.0E-3). We found that miR-509-3p attenuated migration and disrupted multi-cellular spheroids in HEYA8, OVCAR8, SKOV3, OVCAR3, OVCAR4 and OVCAR5 cell lines. Consistent with disrupted spheroid formation, in TCGA data miR-509-3p's most strongly anti-correlated predicted targets were enriched in components of the extracellular matrix (ECM). We validated the Hippo pathway effector YAP1 as a direct miR-509-3p target. We showed that siRNA to YAP1 replicated 90% of miR-509-3p-mediated migration attenuation in OVCAR8, which contained high levels of YAP1 protein, but not in the other cell lines, in which levels of this protein were moderate to low. Our data suggest that the miR-509-3p/YAP1 axis may be a new druggable target in cancers with high YAP1, and we propose that therapeutically targeting the miR-509-3p/YAP1/ECM axis may disrupt early steps in multi-cellular spheroid formation, and so inhibit metastasis in epithelial ovarian cancer and potentially in other cancers.


Subject(s)
Cell Movement/genetics , Gene Expression Regulation, Neoplastic/genetics , MicroRNAs/genetics , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/pathology , Adaptor Proteins, Signal Transducing/biosynthesis , Biomarkers, Tumor/analysis , Carcinoma, Ovarian Epithelial , Cell Line, Tumor , Female , Humans , Kaplan-Meier Estimate , Neoplasms, Glandular and Epithelial/genetics , Neoplasms, Glandular and Epithelial/mortality , Ovarian Neoplasms/genetics , Ovarian Neoplasms/mortality , Phosphoproteins/biosynthesis , Spheroids, Cellular/pathology , Transcription Factors , YAP-Signaling Proteins
3.
Cancer Cell ; 29(3): 394-406, 2016 Mar 14.
Article in English | MEDLINE | ID: mdl-26977886

ABSTRACT

Malignant rhabdoid tumors (MRTs) are rare lethal tumors of childhood that most commonly occur in the kidney and brain. MRTs are driven by SMARCB1 loss, but the molecular consequences of SMARCB1 loss in extra-cranial tumors have not been comprehensively described and genomic resources for analyses of extra-cranial MRT are limited. To provide such data, we used whole-genome sequencing, whole-genome bisulfite sequencing, whole transcriptome (RNA-seq) and microRNA sequencing (miRNA-seq), and histone modification profiling to characterize extra-cranial MRTs. Our analyses revealed gene expression and methylation subgroups and focused on dysregulated pathways, including those involved in neural crest development.


Subject(s)
Gene Expression Regulation, Developmental/genetics , Rhabdoid Tumor/genetics , Cell Line, Tumor , Chromosomal Proteins, Non-Histone/genetics , DNA Methylation/genetics , DNA-Binding Proteins/genetics , Gene Expression/genetics , Histones/genetics , Humans , MicroRNAs/genetics , SMARCB1 Protein , Transcription Factors/genetics , Transcriptome/genetics
4.
J Bacteriol ; 186(22): 7783-95, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15516593

ABSTRACT

Rhodococcus sp. strain RHA1, a potent polychlorinated-biphenyl (PCB)-degrading strain, contains three linear plasmids ranging in size from 330 to 1,100 kb. As part of a genome sequencing project, we report here the complete sequence and characterization of the smallest and least-well-characterized of the RHA1 plasmids, pRHL3. The plasmid is an actinomycete invertron, containing large terminal inverted repeats with a tightly associated protein and a predicted open reading frame (ORF) that is similar to that of a mycobacterial rep gene. The pRHL3 plasmid has 300 putative genes, almost 21% of which are predicted to have a catabolic function. Most of these are organized into three clusters. One of the catabolic clusters was predicted to include limonene degradation genes. Consistent with this prediction, RHA1 grew on limonene, carveol, or carvone as the sole carbon source. The plasmid carries three cytochrome P450-encoding (CYP) genes, a finding consistent with the high number of CYP genes found in other actinomycetes. Two of the CYP genes appear to belong to novel families; the third belongs to CYP family 116 but appears to belong to a novel class based on the predicted domain structure of its reductase. Analyses indicate that pRHL3 also contains four putative "genomic islands" (likely to have been acquired by horizontal transfer), insertion sequence elements, 19 transposase genes, and a duplication that spans two ORFs. One of the genomic islands appears to encode resistance to heavy metals. The plasmid does not appear to contain any housekeeping genes. However, each of the three catabolic clusters contains related genes that appear to be involved in glucose metabolism.


Subject(s)
Plasmids/genetics , Polychlorinated Biphenyls/metabolism , Rhodococcus/genetics , Amino Acid Sequence , Bacterial Proteins/genetics , Base Sequence , Biodegradation, Environmental , Cytochrome P-450 Enzyme System/genetics , Gene Transfer, Horizontal , Molecular Sequence Data , Open Reading Frames/genetics , Phylogeny , Replication Origin , Rhodococcus/metabolism , Sequence Analysis, DNA , Telomere
SELECTION OF CITATIONS
SEARCH DETAIL
...